Technical Analysis for VRCA - Verrica Pharmaceuticals Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Up | Up | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Upper Bollinger Band Walk | Strength | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Calm After Storm | Range Contraction | -5.25% | |
Upper Bollinger Band Walk | Strength | -5.25% | |
Wide Bands | Range Expansion | -5.25% | |
Upper Bollinger Band Touch | Strength | -5.25% | |
Slingshot Bullish | Bullish Swing Setup | -4.73% | |
Upper Bollinger Band Walk | Strength | -4.73% | |
Wide Bands | Range Expansion | -4.73% | |
Overbought Stochastic | Strength | -4.73% |
Alert | Time |
---|---|
Down 3% | 1 day ago |
Fell Below Previous Day's Low | 1 day ago |
Down 2 % | 1 day ago |
Down 1% | 1 day ago |
Up 1% | 2 days ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/13/2024
Verrica is a pharmaceutical company focused on identifying, developing and commercializing innovative pharmaceutical products for the treatment of skin diseases with significant unmet needs. The company’s lead product candidate, VP-102, is currently being evaluated in two Phase 3 clinical trials for the treatment of molluscum and in a Phase 2 clinical trial for the treatment of common warts.
Sector: Healthcare
Industry: Biotechnology
Keywords: Pharmaceutical Medication Pharmaceutical Products Clinical Trial Skin Diseases Treatment Of Skin Diseases Common Warts
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Pharmaceutical Medication Pharmaceutical Products Clinical Trial Skin Diseases Treatment Of Skin Diseases Common Warts
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 11.4 |
52 Week Low | 2.86 |
Average Volume | 201,995 |
200-Day Moving Average | 5.16 |
50-Day Moving Average | 6.62 |
20-Day Moving Average | 7.67 |
10-Day Moving Average | 8.44 |
Average True Range | 0.65 |
RSI (14) | 64.79 |
ADX | 49.51 |
+DI | 41.65 |
-DI | 10.41 |
Chandelier Exit (Long, 3 ATRs) | 9.46 |
Chandelier Exit (Short, 3 ATRs) | 8.48 |
Upper Bollinger Bands | 9.60 |
Lower Bollinger Band | 5.73 |
Percent B (%b) | 0.76 |
BandWidth | 50.49 |
MACD Line | 0.69 |
MACD Signal Line | 0.56 |
MACD Histogram | 0.1299 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 9.62 | ||||
Resistance 3 (R3) | 9.71 | 9.50 | 9.46 | ||
Resistance 2 (R2) | 9.50 | 9.26 | 9.45 | 9.40 | |
Resistance 1 (R1) | 9.08 | 9.11 | 8.98 | 8.99 | 9.35 |
Pivot Point | 8.87 | 8.87 | 8.81 | 8.82 | 8.87 |
Support 1 (S1) | 8.45 | 8.63 | 8.35 | 8.36 | 7.99 |
Support 2 (S2) | 8.24 | 8.48 | 8.19 | 7.94 | |
Support 3 (S3) | 7.82 | 8.24 | 7.88 | ||
Support 4 (S4) | 7.73 |